D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 45.34 CNY -1.82% Market Closed
Market Cap: 18.8B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note
Dizal Jiangsu Pharmaceutical Co Ltd
/
Balance Sheet
/
Other Current Liabilities

Dizal Jiangsu Pharmaceutical Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dizal Jiangsu Pharmaceutical Co Ltd
Other Current Liabilities Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Other Current Liabilities
¥57.2m
CAGR 3-Years
76%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Current Liabilities
¥1.5B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Current Liabilities
¥1.9B
CAGR 3-Years
53%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other Current Liabilities
¥343.5m
CAGR 3-Years
27%
CAGR 5-Years
12%
CAGR 10-Years
27%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Current Liabilities
¥2.5B
CAGR 3-Years
19%
CAGR 5-Years
74%
CAGR 10-Years
62%
Imeik Technology Development Co Ltd
SZSE:300896
Other Current Liabilities
¥121.8m
CAGR 3-Years
33%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Other Current Liabilities?
Other Current Liabilities
57.2m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Other Current Liabilities amounts to 57.2m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
17%

Over the last year, the Other Current Liabilities growth was 154%. The average annual Other Current Liabilities growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 76% over the past three years , 17% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 198,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.